The release of endogenous dopamine (DA) from rat striatal tissue was studied in an in vitro superfusion system following hormonal manipulations in vivo. Progesterone treatment in estrogen-primed ovariectomized female rats potentiated DA release stimulated either by amphetamine or potassium (K+). In addition, the amount of striatal DA released in response to K+-stimulation was influenced by the light-dark cycle. We conclude that striatal DA release is modulated by ovarian hormones, and suggest that ovarian hormone modulation of presynaptic striatal DA activity may contribute to well-known estrous cycle dependent variations in some non-reproductive behaviors.
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Endogenous ovarian steroid hormones may influence the functional activity of mesostriatal dopamine (DA) neurons by modulating presynaptic DA activity 1,4. For example, in the female rat, treatment with a synthetic estrogen-progesterone combination increases DA synthesis and turnoverk In addition, the amphetamine (AMPH)-stimulated release of endogenous DA from striatal tissue in vitro varies with the estrous cycle, and is attenuated by ovariectomy (OVX) 4. Progesterone treatment in estrogen-primed OVX rats reinstates normal levels of AMPH-stimulated striatal DA release 4. However, it is not known whether this effect of ovarian hormones is specific to AMPH-stimulated DA release. To understand how ovarian hormones influence striatal DA release, it is important to determine if they also modulate the release of DA stimulated by other mechanisms. In the experiment reported here we compared the influence of progesterone treatment in estrogen-primed OVX rats on AMPH-stimulated non-vesicular DA release 15 with the exocytotic DA release induced by depolarization with high extracellular concentrations of potassium (K+). In preliminary studies, we noted that the light-dark cycle had an influence on DA release. Therefore, the effects of ovarian hormones on striatal DA release were studied under 2 different lighting conditions. Adult female Holtzman rats (Madison, WI) were individually housed on a 14 h-10 h, light-dark cycle in 1 of 2 colony rooms: (1) normal light-dark cycle, lights on at 06.00 h; (2) reversed light-dark cycle, lights off 08.30 h. Two weeks after OVX the animals received either 3 daily injections (s.c.) of peanut oil (0.1 ml) or 5.0/~g estradiol benzoate (EB) in peanut oil. On the 4th day they received an injection of either oil or 1.2 mg of progesterone (P) in oil between 06.00 and 09.00 h, and were then decapitated 4 h later. Therefore, half of the animals were killed when lights were on in the colony room (OVX[oil] : light, n = 6; and OVX[EB+P]:Iight, n = 5) and half when the lights were off (OVX [oil] :dark, n = 5; and OVX [EB+P] :dark, n = 5).
Following decapitation, striatai tissue was rapidly removed from the brain, chopped into 1 mm 3 pieces and placed in a superfusion chamber that was positioned in a constant temperature bath (37 °C). A modified Krebs-Ringer phosphate medium (pH 7.4) flowed through the chamber at a rate of 100/A/min. After a 75-min stabilization period, samples of the effluent were collected over 5-min intervals. These ef-
